Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease [prepared by Alan M. Garber ... and others]

Format:

Book

Government document

Contributor:

Garber, Alan M.

United States. Congress. Office of Technology Assessment

Series:

Background paper (United States. Congress. Office of Technology Assessment)

Background paper

Language:

English

Subjects (All):

Gaucher disease--Treatment--United States.

Gaucher disease.

Orphan drugs--United States.

Orphan drugs.

Pharmaceutical policy--United States.

Pharmaceutical policy.

Physical Description:

1 online resource

Distribution:

For sale by the U.S. Government Printing Office, Superintendent of Documents [1992]

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

Washington, DC Office of Technology Assessment : [1992]

Notes:

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection. Reuse except for individual research requires license from ProQuest, LLC

Includes bibliographical references (pages 29-34)

Electronic reproduction. [Bethesda, Md.] : ProQuest, 2004. digital, PDF file. ProQuest U.S. Congressional Research Digital Collection. Mode of access: World Wide Web via ProQuest website

Vendor supplied data

Other Format:

Microfiche version Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease CIS 92 J952-64

Print version Federal and private roles in the development and provision of alglucerase therapy for Gaucher disease

Publisher Number:

CMP-1992-OTA-0068

Access Restriction:

Restricted for use by site license